Latest healthtech and biotech deals
The largest from last week:
🇺🇸 Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, finished a $132M Series B financing round led by RA Capital Management.
🇺🇸 Kate Farms, the market leader in bringing plant-based nutrition into healthcare, finished a $75M Series C round of funding, led by Novo Holdings.
🇺🇸 Ceribell, tech platform designed to address the need for easier and faster diagnosis in patients with suspicion of seizure, closed a $50M financing round led by new investor Ally Bridge Group, with participation from existing shareholders.
🇺🇸 Scratchpay, a California fintech company reimagining patient financing, has raised $35M in Series C funding.
Other notable deals from around the globe:
🇺🇸 Naveris, a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, received $33M expansion of its Series A financing, bringing the total investment in Naveris to $51M.
🇺🇸 Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, has raised a $17M funding round.
🇩🇪 AIgnostics, a spin-off from Charité – Universitätsmedizin Berlin, which is developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, closed a €14M Series A financing round.
Read up on all the latest health deals in Dealroom.co